Safety of discontinuation of anti-coagulation in patients with continuous-flow left ventricular assist devices.
Divisions of Cardiology, University of Minnesota, Minneapolis, Minnesota.
Forum
F
Kamdar
Divisions of Cardiology, University of Minnesota, Minneapolis, Minnesota.
Peter
P
Eckman
Cardiothoracic Surgery, University of Minnesota, Minneapolis, Minnesota.
Ranjit
R
John
D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006471:Gastrointestinal Hemorrhage / Q000453:epidemiology; D006333:Heart Failure / Q000628:therapy*; D006353:Heart-Assist Devices / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D013927:Thrombosis / Q000453:epidemiology* / Q000517:prevention & control*; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use; D028761:Withholding Treatment
D000925:Anticoagulants; D014859:Warfarin; D001241:Aspirin